Excellent
Fully Aligned
Patient Risk:
Low
Summary
The AI claim that Pacerone can cause pulmonary toxicity, hepatic toxicity/injury, and can exacerbate/worsen cardiac arrhythmias is directly supported by the provided label warnings/precautions (Sections 5.2, 5.3, and 5.4) with no contradictions.
Category Scores
Accurate Statements
Pacerone can cause pulmonary toxicity.
Supported by Section 5.2 Pulmonary Toxicity (clinical syndrome consistent with pulmonary toxicity; reported rates up to 17%; fatal in about 10%).
Pacerone can cause hepatic toxicity/injury.
Supported by Section 5.3 Hepatic Injury (Pacerone can cause life-threatening hepatic injury; monitoring of liver transaminases and guidance to discontinue or reduce dose if thresholds exceeded).
Pacerone can exacerbate/worsen cardiac arrhythmias.
Supported by Section 5.4 Worsened Arrhythmia (can exacerbate presenting arrhythmia and can cause new ventricular fibrillation/incessant ventricular tachycardia and polymorphic ventricular tachycardia associated with QTc prolongation/TdP).
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated statements are warnings present in the label; the response does not omit required safety thresholds or management instructions within the scope of the single evaluated claim.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement